TNBCs account for approximately 10 to 20% of all breast cancers and are characterized by the lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Here, ERBB2 is linked to breast carcinoma.